Lifevantage Corp
About Lifevantage Corp
Lifevantage Corp is engaged in the identification, research, development, and distribution of nutraceutical dietary supplements and skincare products. It offers products such as Protandim, a scientifically-validated dietary supplement; LifeVantage TrueScience, an anti-aging skincare product; Axio energy drink mixes; and PhysIQ, a weight management system and other product Geographically, its products are sold in the regions of the United States, Japan, Hong Kong, Australia, Canada, Philippines, Mexico, Thailand, the United Kingdom, and the Netherlands.
This profile is unclaimed. An authorized representative can claim it to add details and earn the Verified badge.
Financial summary
- Revenue FY2025
- $228.5M
- Net income
- $9.8M
- Total assets
- $72.0M
- Market cap
- $125.8M
- Gross margin
- 80.4%
- Operating margin
- 5.3%
- Net margin
- 4.3%
Source: SEC EDGAR · updated Jun 7, 2026
Revenue & profit trend
Financial statements
Income statement
- Revenue
- $228.5M
- Cost of revenue
- $44.9M
- Gross profit
- $183.7M
- Operating expenses
- $171.5M
- Operating income
- $12.2M
- Income tax
- $2.4M
- Net income
- $9.8M
- EPS (basic)
- $0.80
- EPS (diluted)
- $0.75
Balance sheet
- Total assets
- $72.0M
- Current assets
- $50.9M
- Total liabilities
- $37.3M
- Current liabilities
- $27.2M
- Shareholders’ equity
- $34.6M
Cash flow
- Operating cash flow
- $11.9M
- Investing cash flow
- -$1.4M
- Financing cash flow
- -$7.6M
- Net cash flow
- $3.3M
Statements via Polygon.io (SEC filings)
15-minute delayed · data by Polygon.io
Past year
52-week range
- Market cap
- $125.8M
- P/E ratio
- 14.3
- EPS (diluted)
- $0.75
- Dividend yield
- 1.87%
- Shares outstanding
- 11.8M
- Open
- —
- Day range
- –
- Prev close
- —
- Volume
- —
- IPO date
- Mar 10, 1997
Market data by Polygon.io · prices are 15-minute delayed
At a glance
- Profitable — net income of $9.8M in FY2025.
- Revenue declined 2% from FY2020 to FY2025.
- Gross margin of 80.4%, net margin 4.3%.
- Trading 26% below its 52-week high.
- Pays a dividend yielding about 1.87% annually.
- Valued at a price-to-earnings (P/E) ratio of 14.3.
Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.
No reviews yet. Be the first to review Lifevantage Corp.
Write a review
News about Lifevantage Corp
News & sentiment via Polygon.io
